Potent and selective hydroxycarboxylic acid receptor 2 (HCA2
, GPR109A) full agonist; exhibits greater potency than niacin in a whole cell HTRF-cAMP assay (EC50
values are 12.9 and 51 nM respectively). Exhibits no binding at the GRP109B receptor.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[α]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.